268 related articles for article (PubMed ID: 21917301)
1. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
Gerotziafas GT; Galea V; Mbemba E; Khaterchi A; Sassi M; Baccouche H; Prengel C; van Dreden P; Hatmi M; Bernaudin JF; Elalamy I
Thromb Res; 2012 Jun; 129(6):779-86. PubMed ID: 21917301
[TBL] [Abstract][Full Text] [Related]
2. Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells.
Rousseau A; Larsen AK; Van Dreden P; Sabbah M; Elalamy I; Gerotziafas GT
Int J Oncol; 2017 Dec; 51(6):1747-1756. PubMed ID: 29075790
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine.
Yates KR; Welsh J; Echrish HH; Greenman J; Maraveyas A; Madden LA
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):680-7. PubMed ID: 21941170
[TBL] [Abstract][Full Text] [Related]
4. OC-03 - Modelisation of the procoagulant properties of cancer cells and their capacity to alter the antithrombotic efficiency of LMWHs and specific inhibitors of factor Xa.
Gerotziafas GT; Rousseau A; van Dreden P; Mbemba E; Gkalea V; Khaterchi A; Larsen A; Elalamy I
Thromb Res; 2016 Apr; 140 Suppl 1():S169. PubMed ID: 27161675
[TBL] [Abstract][Full Text] [Related]
5. Leptin upregulates tissue factor expression in human breast cancer MCF-7 cells.
Napoleone E; Cutrone A; Cugino D; Latella MC; Zurlo F; Iacoviello L; de Gaetano G; Donati MB; Lorenzet R
Thromb Res; 2012 May; 129(5):641-7. PubMed ID: 21840575
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells.
AmraneDjedidi R; Rousseau A; Larsen AK; Elalamy I; Van Dreden P; Gerotziafas GT
Thromb Res; 2020 Mar; 187():170-179. PubMed ID: 32006891
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.
Taniguchi T; Kakkar AK; Tuddenham EG; Williamson RC; Lemoine NR
Cancer Res; 1998 Oct; 58(19):4461-7. PubMed ID: 9766679
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
9. Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer.
Rousseau A; Van Dreden P; Khaterchi A; Larsen AK; Elalamy I; Gerotziafas GT
Int J Oncol; 2017 Dec; 51(6):1793-1800. PubMed ID: 29075792
[TBL] [Abstract][Full Text] [Related]
10. All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells.
Marchetti M; Russo L; Balducci D; Falanga A
Thromb Res; 2011 Oct; 128(4):368-74. PubMed ID: 21458031
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines.
Kirszberg C; Lima LG; Da Silva de Oliveira A; Pickering W; Gray E; Barrowcliffe TW; Rumjanek VM; Monteiro RQ
Melanoma Res; 2009 Oct; 19(5):301-8. PubMed ID: 19550359
[TBL] [Abstract][Full Text] [Related]
12. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model.
Hobbs JE; Zakarija A; Cundiff DL; Doll JA; Hymen E; Cornwell M; Crawford SE; Liu N; Signaevsky M; Soff GA
Thromb Res; 2007; 120 Suppl 2():S13-21. PubMed ID: 18023707
[TBL] [Abstract][Full Text] [Related]
13. Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin.
Rousseau A; Van Dreden P; Mbemba E; Elalamy I; Larsen A; Gerotziafas GT
Thromb Res; 2015 Dec; 136(6):1273-9. PubMed ID: 26489727
[TBL] [Abstract][Full Text] [Related]
14. The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents.
Tran HCM; Mbemba E; Mourot N; Faltas B; Rousseau A; Lefkou E; Sabbah M; van Dreden P; Gerotziafas G
Thromb Res; 2024 Jun; 238():172-183. PubMed ID: 38723522
[TBL] [Abstract][Full Text] [Related]
15. Graft Product for Autologous Peripheral Blood Stem Cell Transplantation Enhances Thrombin Generation and Expresses Procoagulant Microparticles and Tissue Factor.
Sidibe F; Spanoudaki A; Vanneaux V; Mbemba E; Larghero J; Van Dreden P; Lotz JP; Elalamy I; Larsen AK; Gerotziafas GT
Clin Appl Thromb Hemost; 2018 May; 24(4):684-690. PubMed ID: 28681632
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the antithrombotic fingerprint of the branded and copies of the low-molecular-weight enoxaparin using thrombin generation assay.
Gerotziafas GT; Rouseau A; Mbemba E; Khartechi A; Van Dreden P; Walenga J; Fareed J; Elalamy I
Clin Appl Thromb Hemost; 2015 Nov; 21(8):697-704. PubMed ID: 26023170
[TBL] [Abstract][Full Text] [Related]
17. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
[TBL] [Abstract][Full Text] [Related]
18. Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adenocarcinoma.
Kakkar AK; Chinswangwatanakul V; Lemoine NR; Tebbutt S; Williamson RC
Br J Surg; 1999 Jul; 86(7):890-4. PubMed ID: 10417560
[TBL] [Abstract][Full Text] [Related]
19. The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.
Sassi M; Chakroun T; Mbemba E; Van Dreden P; Elalamy I; Larsen AK; Gerotziafas GT
Clin Appl Thromb Hemost; 2017 Mar; 23(2):155-163. PubMed ID: 27609342
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells.
Napoleone E; Cutrone A; Cugino D; Amore C; Di Santo A; Iacoviello L; de Gaetano G; Donati MB; Lorenzet R
Thromb Res; 2012 Jun; 129(6):736-42. PubMed ID: 22188725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
